Bone Microcirculation After Remote Ischemic Preconditioning
NCT ID: NCT02554500
Last Updated: 2023-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2015-09-30
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome After Plate Osteosynthesis of Proximal Humerus Fractures Using Continous Passive Motioning Therapy
NCT05952622
Identification of Microcirculation and Inflammation After Minimal-invasive Osteosynthesis of the Proximal Femur
NCT01264172
Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting
NCT01429012
Internal Plate Fixation vs. Plaster in Complete Articular Distal Radial Fractures
NCT02651779
Treatment of Atrophic Nonunion by Preosteoblast Cells
NCT00916981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intact scaphoid bone
Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid bone.
Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Intact metacarpal bone
Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Fractured scaphoid bone
Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone.
Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Fractured metacarpal bone
Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.
Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Intact metatarsal bone
Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metatarsal bone.
Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
* Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone.
* Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.
Exclusion Criteria
* scar tissue above measuring focus
* osteoporosis or comparable bone disease
* medication that influences bones
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Schleswig-Holstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tobias Kisch
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tobias Kisch, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Schleswig-Holstein
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-266-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.